CCCC (C4 Therapeutics Inc) רווח למניה בארבעת הרבעונים האחרונים

The asset value tracked on the GURU.Markets chart, which currently stands at 57.00, refers to C4 Therapeutics, Inc. (CCCC), a biotech firm that developed the TORPEDO system for the complete degradation of harmful proteins via oral delivery. C4 Therapeutics, Inc. (CCCC) relies on collaborations with global pharma behemoths to bring new molecules to market. The brand's high authority among physicians confirms its success in combating severe forms of oncology.
C4 Therapeutics Inc - פילוחים אנליטיים ומדדי מפתח (CCCC)

C4 Therapeutics, Inc. (CCCC) invests in a highly skilled staff of chemists to develop targeted protein degradation methods. The rolling trailing twelve-month (TTM) earnings per share (EPS) trend measures the rate of change in net income, adjusted for one-time items. This indicator allows for an assessment of the efficiency of R&D cost management and RSU packages amid inflationary pressures. By analyzing historical year-over-year EPS growth (TTM), an investor determines the sustainability of the business's profitability.